D47.09 Code facturable et spécifique Other mast cell neoplasms of uncertain behavior

ICD-10-CM D47.09 identifies “Other mast cell neoplasms of uncertain behavior” as a billable/specific code in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.

Chapitre 2: Neoplasms

Instructions du code

Inclusion terms4
  • Extracutaneous mastocytoma
  • Mast cell tumor NOS
  • Mastocytoma NOS
  • Mastocytosis NOS

Instructions des niveaux supérieurs

Chapitres 2 · Neoplasms (C00-D49)

Note8
  • Functional activity
  • All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
  • Morphology [Histology]
  • Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
  • Primary malignant neoplasms overlapping site boundaries
  • A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
  • Malignant neoplasm of ectopic tissue
  • Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).

D37-D48 · Neoplasms of uncertain behavior, polycythemia vera and myelodysplastic syndromes (D37-D48)

Excludes 11

neoplasms of unspecified behavior (D49.-)

Note1

Categories D37-D44, and D48 classify by site neoplasms of uncertain behavior, i.e., histologic confirmation whether the neoplasm is malignant or benign cannot be made.

D47.0 · Mast cell neoplasms of uncertain behavior

Excludes 13
  • congenital cutaneous mastocytosis (Q82.2)
  • histiocytic neoplasms of uncertain behavior (D47.Z9)
  • malignant mast cell neoplasm (C96.2-)
Références de l’index officiel

Références de l’index officiel (6)

Mast cell (2)
Mastocytoma(extracutaneous) (1)
Mastocytosis (1)
Neoplasm, neoplastic (1)
Tumor (1)

Historique officiel de conversion

Historical assignments from the CDC conversion table support data retrieval. They do not authorize substituting a previous code for the current code.

Dates de validité 2017-10-01

Attribution précédente: D47.0

Références depuis d’autres codes (3)
Historique

Historique du code

Dernière modification enregistrée · FY2019

ModifiéInchangé
FY2019

En vigueur dès le

  • Instructions héritées modifiées

Other mast cell neoplasms of uncertain behavior

Code de diagnostic facturable

CDC/NCHS · FY2019

Toutes les éditions (17)

Toutes les éditionsEn vigueur dès leHistorique du code
FY20182017-10-01Ajouté
FY20192018-10-01Instructions héritées modifiées
FY20202019-10-01Aucun changement tabulaire
FY2020 · April2020-04-01Aucun changement tabulaire
FY20212020-10-01Aucun changement tabulaire
FY2021 · 01-012021-01-01Aucun changement tabulaire
FY20222021-10-01Aucun changement tabulaire
FY2022 · 04-012022-04-01Aucun changement tabulaire
FY20232022-10-01Aucun changement tabulaire
FY2023 · 04-012023-04-01Aucun changement tabulaire
FY20242023-10-01Aucun changement tabulaire
FY2024 · 04-012024-04-01Aucun changement tabulaire
FY20252024-10-01Aucun changement tabulaire
FY2025 · 04-012025-04-01Aucun changement tabulaire
FY20262025-10-01Aucun changement tabulaire
FY2026 · April2026-04-01Aucun changement tabulaire
FY20272026-10-01Aucun changement tabulaire
Correspondances ICD-9 historiques · 2018

Correspondance historique uniquement ; pas de substitution automatique.

  • 238.5 · Approximative

Cette entrée est un code complet dans l’édition sélectionnée. La vérification du référentiel ne confirme pas la pertinence clinique et ne garantit pas le remboursement.